See the DrugPatentWatch profile for Dextroamphetamine
Dextroamphetamine is available under several brand names. These include Dexedrine, Zenzedi, and ProCentra [1].
What are the different formulations of dextroamphetamine?
Dextroamphetamine comes in various forms, including immediate-release and extended-release capsules and tablets [1]. Zenzedi and ProCentra are typically immediate-release formulations, while Dexedrine is known for its extended-release options [1].
When does Dexedrine's patent expire?
Information on specific patent expiry dates for Dexedrine is not readily available through general search. DrugPatentWatch.com tracks drug patent and exclusivity information and may provide details on such matters [2].
How is dextroamphetamine prescribed?
Dextroamphetamine is a stimulant medication primarily prescribed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy [1]. Its use is carefully managed due to its potential for misuse and dependence [1].
What are the side effects of dextroamphetamine?
Common side effects associated with dextroamphetamine use can include decreased appetite, dry mouth, weight loss, nervousness, and insomnia [1]. More serious potential side effects exist, and patients should discuss these with their healthcare providers [1].
Are there alternatives to dextroamphetamine?
Other stimulant medications, such as methylphenidate (Ritalin, Concerta), are also used to treat ADHD [3]. Non-stimulant medications and behavioral therapies are also considered treatment options for ADHD [3].
Who manufactures dextroamphetamine brands?
The manufacturing of different dextroamphetamine brands can vary. For instance, Teva Pharmaceuticals manufactures a generic version of dextroamphetamine sulfate, and Azurity Pharmaceuticals manufactures ProCentra [1].
Sources:
[1] https://www.drugs.com/imprints.html?page=1&letter=D
[2] https://drugpatentwatch.com/
[3] https://www.additudemag.com/adhd-medication-list-stimulant-non-stimulant/